Back Pain Lower Back Completed Phase 3 Trials for Oxycodone (DB00497)

Also known as: Low Back Pain (LBP) / Lumbago / Lumbar Pain / Lower Back Pain / Low Back Pain / Low Back Ache / Low-Back Pain / Pains, Low Back / Loin pain / Lumbalgia / Pain back / Back pain / Pain dorsal / Back ache / Backache / Pain over the back / Backache, unspecified / Dorsal pain / Dorsalgia

IndicationStatusPhase
DBCOND0041441 (Back Pain Lower Back)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00361504A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic PainTreatment
NCT00986180NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back PainTreatment
NCT01571362A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back PainTreatment
NCT01427270Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back PainTreatment
NCT01427283A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back PainTreatment
NCT01179828Linking Altered Central Pain Processing and Genetic Polymorphism to Drug Efficacy in Chronic Low Back Pain (Predictio)Basic Science